• Home
  • KINHOO PHARMACEUTICAL CO.,LTD

KINHOO PHARMACEUTICAL CO.,LTD

About KINHOO PHARMACEUTICAL CO.,LTD

Kinhoo Pharmaceutical Co., Ltd., stock code: 831186, as a NEEQ listed enterprise, found in April 2005 with a registered capital of CNY 65.6 million. Kinhoo is a modernized pharmaceutical enterprise integrating pharmaceutical R&D, production and sales, engaged with medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations. Kinhoo has two Manufactu...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2017
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Contact info
Show contact info Hide contact info

Products from KINHOO PHARMACEUTICAL CO.,LTD (3)

  • Sorafenib tosylate

    Product Sorafenib tosylate

    Sorafenib tosylate (CAS No.: 475207-59-1) Indications: For the treatment of patients with advanced renal cell carcinoma (RCC). For the treatment of patients with unresectable hepatocellular carcinoma (HCC). For the treatment of patients with locally recurrent or metastatic, progressive, differentia...
  • Vardenafil hydrochloride

    Product Vardenafil hydrochloride

    Vardenafil hydrochloride (CAS No.: 330808-88-3)Indications: For the treatment of erectile dysfunction.

  • Lenvatinib mesylate

    Product Lenvatinib mesylate

    Lenvatinib mesylate (CAS No.: 857890-39-2)Indications: For the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). For the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid carcinoma (D...